We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Partnership to Launch Wireless Brain Research System

By LabMedica International staff writers
Posted on 07 Jan 2015
Neuroscience research is now going wireless with the use of a new neural activity monitoring system.

Blackrock Microsystems, LLC (Salt Lake City, UT, USA) reported that it has established an agreement with Brown University (Providence, RI, USA) to license and market a wireless neural activity monitoring system that will free neuroscientists from the burdensome wires and cables that have hampered their research efforts for years. More...


The technology was described online December 4, 2014, in the journal Neuron. The wireless neurosensory, developed by the neuroengineering laboratory at Brown University, was found to substantially outperform all other wireless sensors currently on the market. Senior author Arto Nurmikko commented, “This device enables new types of neuroscience experiments with vast amounts of brain data wirelessly and continuously streamed from brain microcircuits.”

Blackrock first presented the system at the Society for Neuroscience’s annual meeting in Washington DC (USA), held in November 2014. The Blackrock system, which includes Brown’s technology, can transmit large amounts of data—via 96 channels at 48 Mbps—from a subject’s brain for up to 48 hours between rechargeable battery replacements. Furthermore, at only 43 g and 60 cubic centimeters, it is more compact than any other wireless brain technology.

Traditional wired neuroscience research systems restrict a person’s movement and make it tremendously hard for researchers to study sleep. Blackrock’s new wireless system eliminates such problems. “This wireless system is a major step forward in brain-interface technology,” said Prof. Florian Solzbacher, PhD, president of Blackrock Microsystems. “We’re working hard to make this technology smaller and longer-lasting. These systems can have every-day, practical uses for people, and we’re determined to make that a reality.”

Blackrock Microsystems is a world-leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology is focused on worldwide the latest advances in brain machine interfaces, implantable bionic technologies, and epilepsy diagnostics.

Related Links:

Blackrock Microsystems
Brown University



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.